Skip to content

Clinical trials

Phase 4 Acute Coronary Syndrome trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Acute Coronary Syndrome Phase: Phase 4 Clear all

227 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20032
20044
20051
20066
20076
20086
200911
201013
20118
201222
201315
201418
201514
201615
20177
20189
20198
20207
202116
20227
20236
20246
20255
202612

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed115
Unknown status56
Recruiting19
Terminated15
Not yet recruiting14
Withdrawn4
Active, not recruiting3
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Shenyang Northern Hospital8
Yonsei University6
Assistance Publique - Hôpitaux de Paris4
Sheba Medical Center4
AstraZeneca3
Deutsches Herzzentrum Muenchen3
Federico II University3
The First Affiliated Hospital with Nanjing Medical University3
University of Zagreb3
Azienda Policlinico Umberto I2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Acute Coronary Syndrome227
Coronary Artery Disease36
Myocardial Infarction22
ST Elevation Myocardial Infarction18
Angina, Unstable13
Cardiovascular Diseases12
Myocardial Ischemia11
Coronary Disease10
Non-ST Elevated Myocardial Infarction10
Atrial Fibrillation8

Trials

Showing 26 to 50 of 227. Each trial links to its page on Pharma Observatory.

127 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.